5 Life Sciences Stocks Insiders Are Buying

When insiders buy shares on the open market, their companies could enjoy bullish times ahead. Corporate insiders often have the inside track on their companies' prospects, and many of them get paid largely in stock options or restricted shares. Besides, insiders probably wouldn't risk plowing too much of their own money into their own company's stock -- reducing their portfolio's diversity, and increasing its risk -- unless they thought the stock might rise.

With that in mind, I screened for companies where at least one insider made an open-market buy in the last 30 days. These five life sciences stocks made the list:


Net No. of Buys

No. of Shares Bought

Total Value

Market Cap (in millions)

Life Technologies (Nasdaq: LIFE  ) 3 20,600 $857,000 $7,038
Pacific Biosciences of California (Nasdaq: PACB  ) 2 165,000 $577,000 $320
Mettler-Toledo International (NYSE: MTD  ) 3 2,000 $283,000 $4,794
Affymetrix (Nasdaq: AFFX  ) 5 195,000 $199,000 $353
Complete Genomics (Nasdaq: GNOM  ) 1 10,000 $79,000 $283

Source: Capital IQ, a division of Standard & Poor's, as of Aug. 17.

When it comes to the number and total value of insider open-market buys, more can be better; I've sorted this table accordingly. Insiders at Life Technologies, which provides systems, consumables, and services that help scientific researchers and commercial markets accelerate scientific exploration, made three open-market purchases worth a total of $857,000. In contrast, one Complete Genomics insider spent $79,000 on open-market buys. Both are bullish signs, but the Life Technologies purchases look more promising.

My Foolish colleague Seth Jason recently expressed concerns about Life Sciences' accounts receivable and days sales outstanding, while noting that neither concern was a red flag. The large insider purchases suggest that there may be good explanations.

Earlier this month, Pacific Biosciences, which ranks No. 2 on this list, plunged after JPMorgan downgraded the stock and cut its target price. The company had just reported better-than-expected earnings on much-better-than-expected revenue. It seems at least two insiders likely disagree with JPMorgan's view.

Foolish takeaway
Insider buying signals that someone who should be in the know is betting that the stock will rise. You can use this list of recent insider purchases as a starting point for further research -- or a good reason to make a contrarian play.

Are these insiders right? To help you find out, the Motley Fool recently introduced a free My Watchlist feature. You can get up-to-date news and analysis by adding companies to your watchlist now:

Fool contributor Cindy Johnson does not currently own shares of any stock in this story. Motley Fool newsletter services have recommended buying shares of Pacific Biosciences of California. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (1) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On September 02, 2011, at 3:18 PM, tombsfool wrote:

    On what day in the 30 preceding August 23 was Pacific Bio priced at $3.4950/share on the open market? Most sources do not show the stock trading so low at any time since issuance.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1542711, ~/Articles/ArticleHandler.aspx, 10/28/2016 8:43:11 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 11 hours ago Sponsored by:
DOW 18,169.68 -29.65 -0.16%
S&P 500 2,133.04 -6.39 -0.30%
NASD 5,215.97 -34.29 -0.65%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
LIFE.DL $0.00 Down +0.00 +0.00%
Life Technologies… CAPS Rating: ***
AFFX.DL $14.01 Down +0.00 +0.00%
Affymetrix CAPS Rating: **
GNOM.DL $0.00 Down +0.00 +0.00%
Complete Genomics CAPS Rating: **
MTD $397.73 Down -1.90 -0.48%
Mettler-Toledo Int… CAPS Rating: ***
PACB $8.50 Down -0.10 -1.16%
Pacific Bioscience… CAPS Rating: ***